Načítá se...
Point-Counterpoint: Meningitis/Encephalitis Syndromic Testing in the Clinical Laboratory
Syndromic panels were first FDA cleared for detection of respiratory pathogens in 2008. Since then, other panels have been approved by the FDA, and most recently, the FilmArray meningitis/encephalitis panel (BioFire, Salt Lake City, UT) has become available. This assay detects 14 targets within 1 h...
Uloženo v:
| Vydáno v: | J Clin Microbiol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society for Microbiology
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5869827/ https://ncbi.nlm.nih.gov/pubmed/29343540 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.00018-18 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|